Expect near-term selling pressure due to dilution and the 20% discount. Watch for potential registration of these shares or further capital raises. The insider participation may signal endorsement, but the deep discount and OTC listing amplify dilution risk.
Price Chart
Executive Summary
Pure Bioscience raised $1.0 million via a private placement, issuing 18,131,096 shares at $0.0553 per share (20% discount to market). Board members Tom Y. Lee and Ivan Chen invested alongside other accredited investors. The capital will fund working capital and general corporate purposes.
Key Financial Metrics
Key Facts
- Raised $1.0 million through private placement of 18,131,096 shares at $0.0553/share.
- Purchase price set at 80% of market price on closing date.
- Director Tom Y. Lee invested approximately $700,000; director Ivan Chen invested $27,650.
- Shares are unregistered restricted securities; proceeds for working capital and general corporate purposes.
- The transaction closed on April 30, 2026; 8-K filed May 5, 2026.
Financial Impact
Dilution of approximately 18.1 million new shares, representing a significant increase in share count for a micro-cap company. The $1.0 million offering is small in absolute terms but large relative to the company's market cap.
Risk Factors
- Significant dilution to existing shareholders, potentially exceeding 50% of prior outstanding shares.
- Low liquidity on OTC markets may exacerbate price impact from resales.
- Company may require additional financing if cash burn continues.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-021329 |
| Document: form8-k.htm | 0001493152-26-021329 |
| Document: 0001493152-26-021329-index-headers.html | 0001493152-26-021329 |
| Document: 0001493152-26-021329-index.html | 0001493152-26-021329 |
| Document: 0001493152-26-021329.txt | 0001493152-26-021329 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 7d ago | 8-K | $0.0800 $0.0800 | · 0.00% | ▼ −1.18% | $0.0870 (−8.75%) |
Jun 15, 2026 19w ago | 8-K | $0.0600 $0.0800 | ▲ +33.33% | ▲ +34.58% | $0.0870 (+45.00%) |
May 5, 2026 25w ago | 8-K | $0.0700 $0.0700 | · 0.00% | ▼ −0.33% | $0.0870 (−24.29%) |
Mar 17, 2026 32w ago | 8-K | $0.0800 $0.0800 | · 0.00% | ▲ +1.40% | $0.0870 (+8.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers